Ausgabe 11/2020
Inhalt (12 Artikel)
Integrating Genetics and the Plasma Proteome to Predict the Risk of Type 2 Diabetes
Julia Carrasco Zanini, Maik Pietzner, Claudia Langenberg
Role of Agents for the Treatment of Diabetes in the Management of Nonalcoholic Fatty Liver Disease
Jeffrey Budd, Kenneth Cusi
The Role of Socioeconomic Status in Latino Health Disparities Among Youth with Type 1 Diabetes: a Systematic Review
Daniel Mello, Deborah Wiebe
A Review of the Current Evidence: Impact of Metabolic Surgery on Diabetes Outcomes and Obesity-Associated Macrovascular Complications
Karim G. Kheniser, Ali Aminian, Sangeeta R. Kashyap
What Makes Sodium-Glucose Co-Transporter-2 Inhibitors Stand out in Heart Failure?
Muhammad Shahzeb Khan, Muthiah Vaduganathan
Do Women with Diabetes Need More Intensive Action for Cardiovascular Reduction than Men with Diabetes?
Jürgen Harreiter, Helena Fadl, Alexandra Kautzky-Willer, David Simmons
The Road to Approval: a Perspective on the Role of Icosapent Ethyl in Cardiovascular Risk Reduction
Xiaowen Wang, Subodh Verma, R. Preston Mason, Deepak L. Bhatt
Novel Targets in Glucose Homeostasis and Obesity—Lesson from Rare Mutations
Bing Feng, Pingwen Xu, Yanlin He
Current State of Diabetes Mellitus Prevalence, Awareness, Treatment, and Control in Latin America: Challenges and Innovative Solutions to Improve Health Outcomes Across the Continent
M. Larissa Avilés-Santa, Alberto Monroig-Rivera, Alvin Soto-Soto, Nangel M. Lindberg
Social Determinants of Poor Management of Type 2 Diabetes Among the Insured
Minal R. Patel
Thyroid Hormone Signalling Alteration in Diabetic Nephropathy and Cardiomyopathy: a “Switch” to the Foetal Gene Programme
Polyxeni Mantzouratou, Angelo Michele Lavecchia, Rubina Novelli, Christodoulos Xinaris
Tissue-Specific Fructose Metabolism in Obesity and Diabetes
Robert N. Helsley, Francois Moreau, Manoj K. Gupta, Aurelia Radulescu, Brian DeBosch, Samir Softic